20/20 GeneSystems, Inc. (Equity)
Funding Details
- Awarder
- StartEngine
- Date Award
- June 13, 2024
- Vertical
- Digital Diagnostics
- Funding URL
- View Funding Page
- Premoney Valuation
- $1,000,000
- Valuation
- $57,380,000
- Funding Amount:
- $1,000,000
Company Info
- Founding Year
- Not provided
- Traction
- The company has seen significant revenue growth, with over 300% year-over-year increase. They have partnerships with China’s Ping An Ventures, a major Healthcare AI company, and thousands of investors.
- Revenue Amount
- $30,000,000
- Organizations Involved
- China’s Ping An Ventures, thousands of investors
- Founders
- Not provided
- Company Description
- 20/20 GeneSystems is a digital diagnostics company focused on reducing cancer mortality through early detection. They have expanded their test menu to include Covid-19 testing solutions. The company leverages real-world data and machine learning to improve the accuracy of clinical lab testing, with plans to expand to heart disease and other chronic conditions.
- Market
- Healthcare
- Location
- Wilmington, DE, US
- Coinvestors
- China’s Ping An Ventures, thousands of investors